Angiogenic parameters and the risk factors for thrombosis in polycythemia vera
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2018, Vol 72, Issue
Abstract
Aim: The assessment of angiogenic parameters in so-called “liquid tumors”, such as myeloproliferative neoplasms, remains an open clinical issue. The aim of the study is to evaluate the concentration of vascular endothelial growth factor (VEGF-A) and soluble receptors sVEGFR-1 and sVEGFR-2 in relations to risk factors of thrombosis in patients with polycythemia vera (PV). Material/Methods: A total of 45 patients suffering from newly diagnosed PV and 30 healthy volunteers were enrolled into the study. Polycythemia vera was diagnosed according to the WHO (2008) criteria. In the citrated plasma samples VEGF-A, sVEGFR-1 and sVEGFR-2 were measured using ELISA tests. Results: VEGF-A concentration was three-fold higher and sVEGFR-2 significantly lower in PV patients as compared to the control group. VEGF-A concentration was significantly higher in PV patients with JAK2V617F mutation, as compared to patients without this mutation. SVEGFR-1 and sVEGFR-2 concentrations were similar in the analyzed subgroups. In PV patients with an increased number of white blood cells (WBCs), the above upper reference value (≥10 G/l), VEGF-A concentration was two-fold higher than in patients with WBCs number <10 G/l. However, sVEGFR-1 and sVEGFR-2 concentrations did not differ between the analyzed subgroups. Analysis of correlations revealed only one relation between VEGF-A and WBCs number. Conclusions: Increased VEGF-A and decreased sVEGFR-2 concentrations in polycythemia vera patients as compared to the control group indicate an intensification of the process of angiogenesis. A higher concentration of VEGF-A in PV patients with leukocytosis and a positive correlation between WBCs number and VEGF-A reflect the potential role of VEGF-A in the pathogenesis of thrombotic complications in hypercoagulable state in PV patients.<br/><br/>
Authors and Affiliations
Joanna Boinska, Grażyna Gadomska, Katarzyna Ziołkowska, Karolina Woźniak, Alicja Bartoszewska-Kubiak, Danuta Rość
Keywords
Related Articles
- EP ID EP345305
- DOI 10.5604/01.3001.0012.1968
- Views 134
- Downloads 0
Amylina w badaniach eksperymentalnych. Fibrylotwórczy polipeptyd amyloidu trzustkowego
W przebiegu cukrzycy typu 2 (diabetes mellitus type 2 DM2, non-insulin dependent diabetes mellitus, NIDDM) oraz w rozwoju guza insulinowego trzustki, obserwuje się w obrębie wysp Langerhansa patologiczne depozyty zwane a...
Menopauza, otyłość a stan kośćca
Dotychczasowe badania wskazują, że otyłość nie jest czynnikiem ryzyka osteoporozy. Zwiększenie masy tłuszczu ustrojowego, może mieć znaczenie zapobiegawcze przed utratą masy kostnej po menopauzie. Przyjmuje się, że korzy...
Wpływ chemioterapii na stężenie adypokin we krwi u pacjentów z rakiem jelita grubego
Role of ghrelin and leptin in the regulation of carbohydrate metabolism. Part I. Ghrelin
Ghrelin is a polypeptide that is excreted by the secretory cells of the gastric and intestinal mucosa, the arcuate nucleus of the hypothalamus as well as by the epsilon cells (ε) located in the pancreatic islets. It play...
Hypomelanoses transmitted from generation to generation
Inherited diseases of pigmentation were among the first traits studied in humans because of their easy recognition. This article presents selected hypopigmentary disorders, which can be divided into hypomelanocytoses and...